Tag: Medicine

HKG:1681 Consun Pharm
Challenger, Dividend Growth

HKG:1681 Consun Pharm

HKG:1681 Consun Pharm The pharmaceutical products of the Company include kidney medicines, contrast medium and others. The Company’s subsidiaries include Brilliant Reach Group Limited, Century International Develop Limited and Grand Reach Company Limited. Through its subsidiaries, the Company is also engaged in the research and development of pharmaceutical products.No interim dividend for the six months ended
30 June 2022. There might be the distribution of a final dividend based on the dividend
level in previous years at the Board meeting to be held for reviewing the results for the
year ending 31 December 2022.

Read More
HKG:1177 Sino Biopharm
Challenger, Dividend Growth

HKG:1177 Sino Biopharm

HKG:1177 Sino Biopharm The Group’s business works in a fully integrated chain which spans from R&D to manufacture and sales of pharmaceutical products, covering a vast array of biopharmaceutical, chemical and modernized Chinese medicines. Interim result 2022 are favorable for dividends (+200%) yet EPS fell 77%

Read More